Zymeworks (ZYME) EBIT (QoQ) (2021 - 2026)
Powered by 
Analysis
Zymeworks (ZYME) EBIT (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Zymeworks | 2.15 Bn | 1.88 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.48% |
| Mar 31, 2026 | -6.72% |
| Dec 31, 2025 | -99.69% |
| Sep 30, 2025 | -3,180.42% |
| Jun 30, 2025 | 97.37% |
| Mar 31, 2025 | -15.29% |
| Dec 31, 2024 | 35.05% |
| Sep 30, 2024 | 20.24% |
| Jun 30, 2024 | -13.45% |
| Mar 31, 2024 | -61.40% |
| Dec 31, 2023 | 29.53% |
| Sep 30, 2023 | 38.58% |
| Jun 30, 2023 | -98.36% |
| Mar 31, 2023 | -108.54% |
| Dec 31, 2022 | 734.25% |
| Sep 30, 2022 | 23.49% |
| Jun 30, 2022 | 9.44% |
| Mar 31, 2022 | -77.94% |
| Dec 31, 2021 | 32.99% |